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1. Introduction 
We reported the existence of membrane adenosine 
receptors coupled to adenylate cyclase in mouse 
thymocytes and splenocytes [l], while our attempts 
to evidence such receptors in pig lymph node lympho- 
cytes were unsuccessful [2]. This nucleoside and 
structural analogues had been claimed to induce cyclic 
AMP (CAMP) accumulation in rat lymphocytes [3], 
human lymphocytes [4,5] and pig lymphocytes [2], 
even if direct stimulation of adenylate cyclase was 
not clearly established. So one can predict that any 
mechanism which regulates the adenosine level may 
affect the intracellular level of CAMP. 
5’-Nucleotidase (EC 3.1.3.5) is an ectoenzyme 
[6,7] which specifically hydrolyses nucleoside 
5’-monophosphates to nucleosides and Pi; we demon- 
strated that lymphocyte 5’-nucleotidase, which is 
inhibited by concanavalin A (Con A) is one of the 
lectin receptors [8,9]. Since the concentration of 
5’-AMP in serum is relatively high (-40 I.IM [lo] ) 
we checked the hypothesis that adenosine resulting 
from 5’-AMP hydrolysis by 5’nucleotidase might 
control the level of CAMP in thymocytes. Here we 
show a 5’-nucleotidase-adenylate cyclase correlation 
through adenosine receptor sites and showed that 
Con A might indirectly control CAMP level through 
the level of adenosine. 
2. Materials and methods 
Thymocytes were prepared from week 4-5 Swiss 
mice as in [ 11. Determination of intracellular CAMP 
levels was carried out using the Amersham Radio- 
chemical Centre kit after purification of cell extracts 
on Dowex resin column as in [2]. 5’-Nucleotidase 
activity was determined using 5’- [‘*PI AMP as 
reported, except that incubation medium was Hank’s 
medium [9]; increases in Pi up to 0.1 M had no effect 
on the enzyme activity (ourselves and [6] ). Adenosine 
uptake from 5’- 13H] AMP was determined after rapid 
centrifugation of lymphocytes from the incubation 
medium through an oil cushion [ 111. 
3. Results 
3,l. Effect of ?-AMP on CAMP accumulation in 
mouse thymocy tes 
Short incubations of mouse thymocytes with 
30 PM 5’-AMP induced large increases in their CAMP 
level (fig.la). The intracellular concentration of 
CAMP (8.0 f 2.0 pmol/lO’ cells) increased within the 
first minutes of exposure to 5’-AMP. The CAMP level 
was maximum (7-lo-fold enhancement, depending 
on experiments) over 15-20 min and remained high 
at 30 min. We measured in the same experiment the 
rate of 5’-AMP hydrolysis, the uptake of adenosine 
from 5’-[3H]AMP (fig.lb) and the increase of CAMP 
content in thymocytes. With 30 PM 5’-AMP the 
hydrolysis rate remained constant during 30 min; 
1800 pmol adenosine 10’ cells were produced in the 
medium, in 15 min. Part of this nucleoside was incor- 
porated into the cells and metabolized [ 111. The rate 
of adenosine uptake remained constant during 15 min 
(490 pmol/lO’ cells in 15 min), then slightly 
decreased between 15 and 30 min. Identical results 
were reported for mouse splenocytes [ 111. 
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3.2. Effect of 6~hlorop~~ne riboside and a.@ 
methytene ADP on .5’-AMP-induced cAMPuccu- 
mulation 
The 5’-AMP-induced increase of thymocyte CAMP 
level could be explained by the fact that adenosine 
which enter the cell through a facilitated process 
[l l] might serve as CAMP precursor, but this seems 
rather unlikely because’: 
(1) 
(2) 
The peak of CAMP accumulation was observed at 
15-20 min while adenosine continued to enter 
the cell with an unchanged metabolism [l 11; 
If 200 PM 6~hloropurine riboside, an jnhibitor 
of adenosine transport [I], was added to the 
incubation medium before 5’-AMP, CAMP accu- 
mulation and 5’-AMP hydrolysis were unchanged 
F&.1.(a) Time course of the effect of 3 X lo-’ M S-AMP on 
CAMP levels in mouse thymocytes. After 20 min equilibra- 
tion 1 ml aliquots of thymocytes in Hank’s medium (IO’ 
cells) were incubated with (e--o) or without (o--o) 
3 X 1 O-’ M 5’-AMP. Trichloroacetic acid (1 ml) was added 
and CAMP levels determined. Results are the mean of 3 
expt. (b) Time courses of $-AMP hydrolysis and adenosine 
uptake by mouse thymocytes. At the same time and under 
the same conditions as for (a) 3 X 10W5 M S-AMP hydro- 
lysis [7] (o--o) by mouse thymocytes and adenosine 
uptake from 5’-AMP [ 1 l] (m---m) were determined. Results 
are expressed in nmol S-AMP hydrolysed and nmol ade- 
nosine incorporated/lO’ cells. 
Table 1 
Effects of AOPC and 6chloropurine riboside on ?-AMP-induced CAMP accumulation, on 
5’-AMP hydrolysis and on adenosine incorporation in mouse thymocytes 
Cell treatment CAMP accumulation 5’-AMP hydrolysed Adenosine incorpo- 
(% of control) (pmol/lO’ cells) rated (pmol/lO’ 
in15min cells) in 15 min 
Control loo+ 10 0 0 
200 PM AOPC 120+ 20 0 0 
200 PM 6Chloro- 
purine riboside llO* 10 0 0 
30 MM 5’AMP 800 * 200 1800 f, 200 490 
200 MM AOPC + 
30 /& S’AMP 2502 20 400 f 100 42 
200 MM Khloro- 
purine riboside + 
30 PM S’AMP 900 + 150 1620 f 100 48 
After 20 min equilibration at 37”C, 10’ cells in 1 ml Hank’s medium were incubated for 10 
min with or without 200 J& AOPC or 200 FM 6~hloropurine riboside, then for 15 min with 
3 X lo-’ M S-AMP. CAMP levels were then determined (control contents were 8.0 ? 2.0 
pmol/lO’ cells). In parallel the concentration of S-AMP hydrolysed and that of adenosine 
incorporated into the cells, under the same conditions, were determined 
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while adenosine incorporation was inhibited by 
90% (table 1). 
These results suggest hat the CAMP accumulation 
induced by .5’-AMP does not occur through an intra- 
cellular process. 
When 200 PM crB-methylene ADP (AOPC), a well- 
known S’nucleotidase inhibitor [ 121, was added to 
the incubation medium, adenosine production was 
inhibited by 80% and CAMP accumulation was only 
22% of that observed in the absence of AOPC 
(table 1). This experiment and the fact that 5’-AMP 
did not directly stimulate adenylate cyclase of thy- 
mocyte homogenates (data not shown) rule out the 
possibility that the stimulation occurs through 
5’-AMP extracellular sites acting exactly as the ade- 
nosine sites [ 11. 
As we clearly established the stimulation of 
thymocyte adenylate cyclase by extracellular ade- 
nosine [l] and as 5’-AMP had to be hydrolysed to 
induce its effect, it is likely that 5’-AMP controls 
CAMP a~~unlulation through the level of adenosine 
produced by 5’nucleotidase. The fact that adenosine 
produced by 5’-AMP hydrolysis in thymocyte homog- 
enates did not stimulate directly the adenylate 
cyclase activity of these homogenates can be explained 
by the presence of endogenous adenosine deaminase 
{ADA); effectively signi~cant stimulations of homog- 
enate adenylate cyclase were observed with sub-,uM 
doses of 2-chloroadenosine, an ADA-resistant ana- 
logue, but necessitated adenosine at >lO I.IM (30% 
stimulation with 100 PM) [I]. 
3.2. Comparison of CAMP accumulation induced by 
exogenous adenosine and by 5’-AMP-derived 
adenos~ne 
5’-AMP caused a dose-dependent increase in 
thymocyte CAMP level with maximal effect near 
4 X IO-’ M (table 2). After 15 min incubation, the 
adenosine resulting from S’AMP hydrolysis increased 
from 1.2-3.6 X 10e6 M when 5’-AMP increased from 
1O-s-1O4 M. At <15 min the amount of adenosine 
can be calculated from the kinetic equation for 
5’-AMP hydrolysis [ 111. Moreover part of this pro- 
duced adenosine enters the cell (fig.1 b); so the amount 
of adenosine able to interact with its extracellular 
binding sites is much lower than that reported in 
table 2 (column 2). 
Exogenous adenosine gave also a dose-dependent 
increase of thymocyte CAMP level; this effect was 
detectable at 5 X IO-’ M adenosine and maximal at 
lo-’ M (table 2 and [l]). With 2 X 10m6 M ade- 
nosine this stimulation was 230 f 10%. If we compare 
this % stimulation with that obtained by similar con- 
centrations of 5’-AMP-derived adenosine (750 + 100% 
for 1.8 X 10m6 M adenosine), it is clear that stimula- 
tion was greater with .5’-AMP, especially if we con- 
sider that the real amount of adenosine produced 
from 5’~AMP is <I .8 X low6 M, as earlier noticed. 
This result may probably be explained by the fact 
that adenosine produced by S’nucleotidase is localized 
near its extracellular receptor sites, which means that 
local adenosine concentrations are higher than the 
bulk concentrations. 
Table 2 
Effects of 5’-AMP and adenosine on cAMP accumulation in mouse thymocytes 
Cell treatment CAMP content Concentrations (IIM) of .5’-AMP hydro- 
% of control lysed or adenosine produceda in 15 min 
Control 
1O-5 M 5’AMP 
3 x lo-$ M S’AMP 
4 x 1O-5 M 5’AMP 
1O-4 M S’AMP 
5 X lo-” M adenosine 
2 X 10v6 M adenosine 
5 x 10e6 M adenosine 
10-s M adenosine 
lOOk 10 0 
350 i 10 1.25 
7.50 t- 100 1.80 
9ao t: 120 2.60 
950 c 150 3.60 
13tIi: 10 
280t 10 
610t 30 
740 i 50 
a These concentrations were calculated by considering no. molecules adenosine pro- 
duced/ml incubation medium in 15 min 
After 20 min equilibration at 37°C 1 ml aliquots of thymocytes in Hank’s medium 
(10’ cells) were incubated in the presence of various nucleotide or nucleoside doses. 
The concentrations of 5’-AMP hydrolysed under the same conditions were also deter- 
mined 
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It is more difficult to compare the maxima of 
stimulation in the two sets of experiments since at 
high adenosine concentrations phosphodiesterase 
inhibition is also involved in CAMP accumulation [2]. 
Nevertheless these results clearly establish a corre- 
lation between 5’nucleotidase and CAMP accu- 
mulation in thymocytes. 
3.3. Effect of Con A on CAMP accumulation induced 
by 5’-AMP 
The fact that Con A inhibits adenosine production 
by 5’nucleotidase [8,9] prompted us to check if this 
lectin could indirectly interact with the CAMP level 
of thymocytes. At mitogenic doses (ourselves and 
[ 131) we found that Con A alone induced a small 
increase (120%) of the CAMP level. This effect was 
maximal at 1 O-l 5 min and was no longer detected 
after 20 min. Con A inhibited the CAMP accumula- 
tion induced by 5’AMP; when the lectin was added 
15 min before 5’-AMP (3 X 10m6 M) CAMP accu- 
mulation decreased from 660-350% of controls 
(without 5’-AMP nor Con A), while hydrolysed 
5’-AMP decreased from 1.54-0.9 X 10e6 M (table 3). 
On the contrary Con A had no effect on the CAMP 
accumulation induced by adenosine (table 3), which 
clearly demonstrated that the decrease by Con A of 
5’-AMP-induced CAMP accumulation was due to 
5’nucleotidase inhibition. 
4. Discussion 
We have reported that adenosine directly stimu- 
lated adenylate cylase of thymocytes and to a lesser 
extent that of splenocytes [ 11, and caused a notice- 
able increase in their intracellular CAMP content. 
Present data show that physiological concentrations 
of 5’-AMP [IO] induce a large enhancement of the 
CAMP content of mouse thymocytes through interac- 
tion of 5’-AMP-derived adenosine with its external 
receptor sites. The stimulation induced by S’-AMP- 
derived adenosine appears to be very important if we 
consider the small amount of nucleoside produced by 
5’-AMP hydrolysis and the high stimulation level. 
This might be explained if 5’nucleotidase is localized 
on the plasma membrane near the adenosine receptor 
sites, which would result in a very high nucleoside 
concentration near these receptors. Under these con- 
ditions it is very difficult to evaluate the part of 
CAMP stimulation due to adenylate cyclase stimulation 
[l] and the part due to phosphodiesterase inhibition 
[2] occurring at high adenosine concentration, but 
the first mechanism seems to be the most efficient 
since stimulation occurred even when adenosine trans- 
port was inhibited. 
The effect of 5’AMP on CAMP accumulation had 
already been reported in mouse neuroblastoma [ 141, 
but the stimulation observed was less important than 
in thymocytes. 
In spite of the well-documented inhibitory role of 
CAMP for various lymphocyte functions [ 151 the 
effects of Con A on CAMP levels during the first 
minutes of stimulation have led to controversial 
hypotheses concerning the role of early CAMP in 
stimulation triggering [16-l 81. Several groups 
observed a transient peak of CAMP accumulation 
induced by Con A in human peripheral lymphocytes 
Table 3 
Effect of Con A on CAMP accumulation induced by either S-AMP or adenosine 
in mouse thymocytes 
Cell treatment CAMP content 
(% of control) 
5’-AMP (PM) hydro- 
lysed in 15 min 
Control 100 * 10 
Con A 120 * 10 
3 X lo-’ M 5’-AMP 660 * 50 1.54 
Con A + 3 X lo-$ M 5’-AMP 350 * 50 0.9 
5 X 10m6 M adenosine 610 i: 30 
Con A + 5 X 10e6 M adenosine 600 f 20 
Cells (10’ cells/ml in Hank’s medium) were pre-equilibrated 20 min at 37°C and 
incubated with or without Con A (10 r&O6 cells) for 15 min, then with 
3 X lo-’ M 5’-AMP or 5 X lo-’ M adenosine for 15 min. The concentrations of 
5’-AMP hydrolysed were determined in parallel as in table 2. 
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(17,181; this effect does not fit the antiproliferative 
properties of CAMP; it was postulated [l8] that it 
was not relevant to the mitogenic action of Con A. 
The role of serum nucleotides has not been con- 
sidered; our results show the importance of the 
presence of S’-AMP in the incubation medium. ATP 
(100 PM) also stimulated cAMP acculnulation (280%; 
data not shown) but we do not know yet if this effect 
is due to adenosine resulting from ATP splitting by 
external ATPase [6,19] and subsequent ADP hydro- 
lysis by non-specific phosphatases [6,20] leading to 
5’-AMP. We established that Con A-induced decrease 
of CAMP accumulation in the presence of 5’-AMP is 
related to the inhibition of 5’-nucleotidase, since the 
lectin had no effect on this accumulation in the pres- 
ence of adenosine itself. This relationship hypothesized 
1211 could not be shown in pig lymphocytes [2], 
probably because a non-ne~i~ble amount of 
5’nucleotidase is removed from these cells during 
their preparation (in preparation). 
In vivo or in the presence of serum the determina- 
tion of basal CAMP level is very difficult for technical 
reasons, but it is evident that this level strongly 
depends upon the nucleotide level and upon the activ- 
ities of the enzymes involved in nucleotide metab- 
olism. 5’-Nucleotidase appears to play a critical role 
in these regulations; it might exert a negative control 
on cell proliferation through adenosine production, 
and this phenomenon could be related to its reduced 
activity in actively dividing cells 122,231 and in 
lymphocytes from leukemic patients 124,251. We 
showed as others [26] that adenosine inhibits lym- 
phocyte proliferation [2,21,27] only when added 
during the first 24 h stimulation, exactly as prosta- 
glandin El or theophylline, classical CAMP increasing 
agents [28]. 
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